Bank of New York Mellon’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-975,210
| Closed | -$45.2M | – | 4304 |
|
|
2019
Q2 | $45.2M | Sell |
975,210
-54,893
| -5% | -$1.54M | 0.01% | 1036 |
|
|
2019
Q1 | $25.1M | Buy |
1,030,103
+50,561
| +5% | +$1.05M | 0.01% | 1417 |
|
|
2018
Q4 | $14M | Sell |
979,542
-52,587
| -5% | -$798K | ﹤0.01% | 1711 |
|
|
2018
Q3 | $15.7M | Sell |
1,032,129
-1,532
| -0.1% | -$23.5K | ﹤0.01% | 1785 |
|
|
2018
Q2 | $17.3M | Sell |
1,033,661
-65,706
| -6% | -$1.05M | ﹤0.01% | 1684 |
|
|
2018
Q1 | $17.9M | Buy |
1,099,367
+91,151
| +9% | +$1.46M | 0.01% | 1632 |
|
|
2017
Q4 | $12.9M | Buy |
1,008,216
+33,871
| +3% | +$385K | ﹤0.01% | 1863 |
|
|
2017
Q3 | $12M | Buy |
974,345
+158,475
| +19% | +$1.47M | ﹤0.01% | 1895 |
|
|
2017
Q2 | $6.83M | Sell |
815,870
-26,206
| -3% | -$214K | ﹤0.01% | 2166 |
|
|
2017
Q1 | $7.53M | Buy |
842,076
+37,974
| +5% | +$404K | ﹤0.01% | 2113 |
|
|
2016
Q4 | $7.07M | Buy |
804,102
+220,725
| +38% | +$1.62M | ﹤0.01% | 2144 |
|
|
2016
Q3 | $3.94M | Sell |
583,377
-64,190
| -10% | -$248K | ﹤0.01% | 2357 |
|
|
2016
Q2 | $2.31M | Buy |
647,567
+685
| +0.1% | +$2.23K | ﹤0.01% | 2625 |
|
|
2016
Q1 | $1.91M | Buy |
646,882
+21,016
| +3% | +$63K | ﹤0.01% | 2685 |
|
|
2015
Q4 | $2.64M | Sell |
625,866
-26,819
| -4% | -$122K | ﹤0.01% | 2554 |
|
|
2015
Q3 | $2.98M | Sell |
652,685
-132,630
| -17% | -$786K | ﹤0.01% | 2507 |
|
|
2015
Q2 | $5.66M | Buy |
785,315
+11,363
| +1% | +$83.9K | ﹤0.01% | 2276 |
|
|
2015
Q1 | $5.7M | Buy |
773,952
+81,311
| +12% | +$579K | ﹤0.01% | 2247 |
|
|
2014
Q4 | $3.28M | Buy |
692,641
+4,544
| +0.7% | +$18K | ﹤0.01% | 2544 |
|
|
2014
Q3 | $2.46M | Buy |
688,097
+46,954
| +7% | +$185K | ﹤0.01% | 2737 |
|
|
2014
Q2 | $2.92M | Sell |
641,143
-11,438
| -2% | -$47.3K | ﹤0.01% | 2668 |
|
|
2014
Q1 | $3.07M | Buy |
652,581
+35,677
| +6% | +$179K | ﹤0.01% | 2596 |
|
|
2013
Q4 | $3.09M | Buy |
616,904
+6,479
| +1% | +$35.3K | ﹤0.01% | 2606 |
|
|
2013
Q3 | $3.8M | Buy |
610,425
+20,641
| +3% | +$123K | ﹤0.01% | 2407 |
|
|
2013
Q2 | $2.68M | Buy |
+589,784
| New | +$3.17M | ﹤0.01% | 2598 |
|
Other funds holding ARRY
Bank of New York Mellon's ARRY Position: Q3 2019 in Review
Bank of New York Mellon sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 975,210 shares — an estimated $45.2M sold.
Bank of New York Mellon first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $45.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Bank of New York Mellon reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Bank of New York Mellon sold 975,210 Array Biopharma Inc shares in Q3 2019, an estimated $45.2M.
- Bank of New York Mellon first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
- Bank of New York Mellon's Array Biopharma Inc position peaked at $45.2M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Bank of New York Mellon's 13F filing for Q3 2019, filed 7 Nov 2019.